Hemophilia A: Efanesoctocog Alfa Treatment Study

We are studying the long-term effects of efanesoctocog alfa on joint health in people with hemophilia A. The trial aims to see how well it prevents joint bleeds and improves quality of life.

1-2 years ≤5 visits Monitoring phase (IV)No Placebo Cost Reimbursement Standard Medicines InjectionHematologyOrthopedics and Traumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Altuvoct

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Efanesoctocog Alfa

Efanesoctocog alfa is a substance that replaces missing clotting factor VIII to prevent and control bleeding in people with hemophilia A.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

University Hospital Centre Zagreb

Department of internal medicine

Zagreb, Croatia

Fakultni Nemocnice Brno

Oddělení klinické hematologie

Brno, Czechia

Fakultni Nemocnice Ostrava

Ambulance krevního centra

Hlučín, Czechia

Sponsor: Swedish Orphan Biovitrum AB (publ)

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.